December 16, 2024 – INCATE (INCubator for Antibacterial Therapies in Europe) is pleased to announce that two ventures have been awarded Stage II funding in its latest round: Kinzbio and the BamA inhibitor project from [...]
More news
We will be joining the hunt for next generation antimicrobial agents December 9-10 in a [...]
We were delighted to present at this event sharing advances in the science and funding [...]
INCATE was part of a Panel on Financing Innovation at the AMR Conference on August [...]
